report-image

Eczema Therapeutics Market Analysis By Treatment(Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin inhibitors, Antibiotics, Immunomodulators, Interleukin inhibitors), By Indication(Atopic dermatitis, Contact dermatitis), Distribution Channel(Hospitals and Clinics, Retail Pharmacies, Online Pharmacies) & Forecast

  • PUBLISHED ON
  • NO OF PAGES
  • 282
  • CATEGORY
  • Healthcare & Life Sciences
The global eczema therapeutics market size was valued at USD 15,000 million in 2021 and is projected to reach around USD 35,000 million in 2030 exhibiting a CAGR of 11% in the forecasted period. The rising prevalence of atopic dermatitis is anticipated to upsurge the market growth. Additionally, favourable reimbursement policies, growing awareness for the treatment and management of eczema, increasing partnerships of major players will support in creating profitable openings for market players. However, side effects related to corticosteroids will be a major challenge impacting negatively the global market growth.
The increased prevalence of atopic dermatitis is boosting the global market growth. There is a high incidence of eczema across the globe. Eczema can be produced by several factors, containing exposure to allergens such as skin irritations such as few fabrics, household cleaners, or soaps; pollen, peanuts, or pet dander; dry skin; stress; and infections. A large patient pool offers substantial opportunities for the growth of the market. Asia has a huge patient population with atopic dermatitis, with China, India, and Japan being the top revenue funders.
The COVID-19 pandemic considerably impacted the eczema therapeutics market. According to an NCBI article issued in March 2022, atopic dermatitis is related with an augmented risk of COVID-19 infection. Also, numerous initiatives were announced to manage COVID-19 patients suffering from atopic dermatitis. For example, as per a June 2020 update, the SECURE-AD Patient survey is intended to help apprehend how the coronavirus pandemic (COVID-19) affects people with atopic eczema. This survey stimulated the patient population with atopic dermatitis globally to participate and report their understanding with COVID-19 infection. Such studies collecting the difficulties in patients with atopic dermatitis diseased with COVID-19 provided the understanding and permissibility for numerous treatments of atopic dermatitis, thus impacting the market growth. Therefore, the pandemic considerably impacted the market's growth throughout the COVID peak periods. Though, after the reduction of strict regulations on patient conferences at healthcare centers, the present market scenario is anticipated to drive growth through the forecasted period.
The significant factors fuelling the market's growth are the growing burden of allergic reactions, an important role played by food allergy, and rising environmental pollution. The increasing burden of allergic reactions, with a substantial role in food allergies, is motivating the market's growth. For instance, Food Allergy Research and Education (FARA) report in 2020 expected that 32 million United States residents have food allergies, containing 5.6 million children under age 18. Approximately 40% of children with food allergies are sensitive to more than one food.
Indication Insights
The indication segment is atopic dermatitis, contact dermatitis, and others. During the forecasted period, the atopic dermatitis segment will be a substantial provider to market growth during the forecasted period. Atopic dermatitis is a chronic, highly pruritic inflammatory skin disorder and is among the most common skin diseases in children. It generally onsets in infantile and often gets slighter or vanishes by adulthood. The development of this segment is accredited to factors such as a strong pipeline background, with several favourable product contenders in numerous stages of clinical development.
Region Insights
North America will dominate the eczema therapeutics market throughout the forecasted period. This region will account for about 40% of the market's growth during the estimated period. The growth of this region is accredited to factors such as favourable reimbursement policies, increasing partnerships of key vendors with contract research organizations in developing nations, and high smart healthcare spending. Furthermore, market growth in this region will be quicker than the growth of the market in regions. The US is the important nation for the eczema therapeutics market in North America.
However, Asia Pacific is expected to record the fastest growth rate throughout the forecasted period. An upsurge in pro-health initiatives, acceptance of better treatments, and increase in consumer awareness are fuelling market growth in this region. Furthermore, the increasing prevalence of atopic dermatitis, growing demand for cost-effective treatment, and rising population significantly contribute to market growth. Asia Pacific markets such as Australia, China, Korea, and Taiwan already have healthcare compensation systems that offer complete analysis for molecular diagnostic tests.
Key Companies Insights
The market for Eczema therapeutics is moderately competitive. With the rising applications of Eczema therapeutics, new players are considering to enter the market. The companies are also involved in activities like joint ventures, acquisitions, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the Eczema therapeutics market, ultimately boosting the market growth. Some of the key companies working in the global Eczema therapeutics market include:
• Pfizer Inc.
• Sanofi
• AbbVie Inc.
• GALDERMA LABORATORIES, L.P.
• Eli Lilly and Company (Dermira)
• Regeneron Pharmaceuticals Inc.
• LEO Pharma Inc.
• Otsuka Pharmaceutical Co., Ltd.
• Novartis AG
• Incyte Corporation
• Other players
Some of the Recent Developments:
• In April 2021, AbbVie announced the postponement of sNDA for the evaluation of RINVOQ for atopic dermatitis teenage and adult patients.
• In September 2020, Kymera Therapeutics Inc. entered into a strategic collaboration with Sanofi to manufacture and commercialize its first-in-class protein degrader therapy aiming IRAK4 in patients with immune-inflammatory diseases such as atopic dermatitis. Such initiatives will fund the growth of the market emphasise during the forecasted period.
Segments
By Treatment
• Corticosteroids
• Emollients/Moisturizers
• Antihistamines
• Calcineurin inhibitors
• Antibiotics
• Immunomodulators
• Interleukin inhibitors
By Indication
• Atopic dermatitis
• Contact dermatitis
• Others
Distribution Channel
• Hospitals and Clinics
• Retail Pharmacies
• Online Pharmacies
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $4250

Only Four Thousand Two Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $5250

Only Five Thousand Two Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $6250

Only Six Thousand Two Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI